VanEck Biotech ETF (NASDAQ:BBH) Sees Large Increase in Short Interest

VanEck Biotech ETF (NASDAQ:BBH) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 7,633 shares, an increase of 50.7% from the March 15th total of 5,065 shares. Based on an average daily volume of 6,538 shares, the short-interest ratio is currently 1.2 days. Currently, 0.4% of the company’s shares are short sold.

Institutional Investors Weigh In On VanEck Biotech ETF

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Farther Finance Advisors LLC increased its position in VanEck Biotech ETF by 66.1% in the third quarter. Farther Finance Advisors LLC now owns 201 shares of the company’s stock worth $33,000 after buying an additional 80 shares during the period. Wealthfront Advisers LLC increased its holdings in shares of VanEck Biotech ETF by 2.3% in the 4th quarter. Wealthfront Advisers LLC now owns 5,513 shares of the company’s stock worth $1,043,000 after acquiring an additional 122 shares during the period. Evelyn Partners Asset Management Ltd lifted its position in VanEck Biotech ETF by 16.9% in the 4th quarter. Evelyn Partners Asset Management Ltd now owns 941 shares of the company’s stock valued at $178,000 after purchasing an additional 136 shares during the last quarter. Empowered Funds LLC acquired a new position in VanEck Biotech ETF during the 4th quarter valued at about $38,000. Finally, Stifel Financial Corp grew its position in VanEck Biotech ETF by 3.3% in the 4th quarter. Stifel Financial Corp now owns 6,848 shares of the company’s stock worth $1,296,000 after purchasing an additional 219 shares during the last quarter. 32.05% of the stock is currently owned by institutional investors and hedge funds.

VanEck Biotech ETF Price Performance

Shares of BBH stock opened at $194.15 on Thursday. The company has a 50-day moving average of $190.83 and a two-hundred day moving average of $188.61. VanEck Biotech ETF has a 1-year low of $139.92 and a 1-year high of $202.91.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.